Bridgeway Capital Management’s CONMED CNMD Stock Holding History

Bridgeway Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Hold	41,000	–	–	0.02%	671
2026 Q1	$1.45M	Sell	41,000 -1,300	-3%	-$52.9K	0.03%	619
2025 Q4	$1.72M	Sell	42,300 -4,000	-9%	-$174K	0.04%	579
2025 Q3	$2.18M	Buy	+46,300	New	+$2.4M	0.05%	527
2021 Q1	–	Sell	-3,700	Closed	-$414K	–	1365
2020 Q4	$414K	Sell	3,700 -700	-16%	-$66.3K	0.01%	1014
2020 Q3	$346K	Hold	4,400	–	–	0.01%	1015
2020 Q2	$317K	Sell	4,400 -1,600	-27%	-$111K	0.01%	1023
2020 Q1	$344K	Buy	+6,000	New	+$553K	0.01%	879

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Bridgeway Capital Management's CNMD Position: Q2 2026 in Review

Bridgeway Capital Management held its CONMED (CNMD) position steady in Q2 2026 at 41,000 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #671.

Bridgeway Capital Management first reported a position in CNMD in Q1 2020 and has held it in 8 quarters since. The position peaked at $2.18M in Q3 2025. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Bridgeway Capital Management held 41,000 shares of CONMED worth $1.34M as of Q2 2026.
Bridgeway Capital Management left its CONMED share count unchanged in Q2 2026.
CONMED made up 0.02% of Bridgeway Capital Management's portfolio in Q2 2026, its #671 holding.
Bridgeway Capital Management first reported a position in CONMED in Q1 2020 and has held it in 8 quarters since.
Bridgeway Capital Management's CONMED position peaked at $2.18M in Q3 2025.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.